Gold digging: Searching for gut microbiota that enhances antitumor immunity

Related Experiment Video

Updated: Nov 21, 2025

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
07:32

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

9.1K

Fengyi Hou1,2, Zhiyuan Pan2, Ruifu Yang2

  • 1Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Journal of Cellular Physiology
|January 16, 2021
PubMed

Insights

The gut microbiota influences cancer immunotherapy effectiveness. Modulating gut bacteria may enhance patient response to immune checkpoint inhibitors (ICIs) like PD-1/PD-L1 and CTLA-4, improving cancer treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Microbiome Research

Background:

  • Immune checkpoint inhibitors (ICIs), including PD-1/PD-L1 and CTLA-4, show significant antitumor effects.
  • Patient response to ICIs varies, limiting their broad clinical application.
  • The gut microbiota plays a crucial role in host immune function and overall health.

Purpose of the Study:

  • To review and classify gut microbes relevant to cancer immunotherapy.
  • To clarify the modulatory functions of gut microbiota in ICI treatment.
  • To assess the impact of gut microbiota on the efficacy of PD-1/PD-L1 and CTLA-4 inhibitors.

Main Methods:

  • Literature review of recent clinical trials.
  • Classification of gut microbes based on taxonomic information.
  • Analysis of studies investigating the gut microbiota-ICI relationship.

Main Results:

  • Specific gut microbial taxa are associated with patient response to ICIs.
  • Gut microbiota composition can influence the effectiveness of immunotherapies.
  • Evidence suggests a link between microbial modulation and improved ICI efficacy.

Conclusions:

  • The gut microbiota is a key factor in determining patient response to cancer immunotherapy.
  • Targeting and modulating the gut microbiota presents a promising strategy to enhance ICI efficacy.
  • Further research into specific microbial interventions could optimize cancer treatment.
Keywords:
CTLA-4ICIsPD-1gut microbiotaimmunotherapy

More Related Videos

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions05:27

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

4.8K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.2K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
871
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
990
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
673
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
8.1K